Ok
Cancel
Don't show this message again
-
Ok CancelDon't show this message again
Using 340B Drugs Across the Continuum of Care: How to Provide Quality Service and Stay Compliant
Michael Glomb, Partner, Feldesman Tucker Leifer Fidell LLP. Sue Veer, CEO, Carolina Health Centers, Inc..
April 9, 2019
-
Understand the risks and rewards of dispensing 340B drugs for your patients across the continuum of care
-
Understand the impact of current federal guidance on dispensing 340B drugs to patients
-
Describe policies and self-audit procedures to minimize risk and maximize patient benefits
-